Comp Set MANGALAM BIOFILCHEM× LASA× VINEETLAB× + ORTINGLOBE + KREBSBIO + ALPA + BALPHARMA + NATCAPSUQ + NECLIFE + AAREYDRUGS + MEDICAMEQ + MEDICO
In ₹ Crore except Per Share
Latest Annual
MANGALAM
FY26
BIOFILCHEM
FY26
LASA
FY26
VINEETLAB
FY26
Peer
Average
Valuation — at last close P/E — ◆ 17.11×— 36.06× 26.59× P/B ◆ 0.45×2.21× 0.47× 1.52× 1.40× -68% EV/EBITDA ◆ -10.12×72.85× -1.14× 11.50× 27.74× -136% Market Cap ₹46.1 Cr ₹47.6 Cr ₹23.4 Cr ₹69.3 Cr ₹46.8 Cr -1% Growth Revenue CAGR 3Y — ◆ -1.85%-42.11% -34.59% -26.18% Revenue CAGR 5Y — ◆ -4.50%-34.11% -24.58% -21.06% Net Income CAGR 3Y — ◆ 70.67%— 8.59% 39.63% Revenue YoY (latest Q) -0.40% ◆ 91.99%-93.87% 39.66% 12.59% -103% Net Income YoY (latest Q) 44.64% -95.47% 83.05% ◆ 274.84%87.47% -49% Profitability EBITDA Margin -6.42% 2.29% -112.98% ◆ 14.27%-32.14% +80% Net Income Margin -19.13% ◆ 9.81%-135.60% 2.70% -41.03% +53% Return on Common Equity -35.23% ◆ 13.81%-51.13% 5.32% -10.67% -230% Return on Capital Employed -22.60% 1.83% -51.42% ◆ 15.62%-11.32% -100% Return on Assets -13.03% ◆ 5.94%-40.63% 1.46% -11.08% -18% Credit & Quality Total Debt/Equity 1.02× ◆ 0.14×0.20× 0.99× 0.44× +130% Interest Coverage -2.04× ◆ 37.37×-89.13× 1.24× -16.84× +88% Scale — latest FY Revenue / Total Income ₹232 Cr ₹28.4 Cr ₹25.1 Cr ₹59.4 Cr ₹37.6 Cr +517% Net Income −₹44.4 Cr ₹2.8 Cr −₹34.1 Cr ₹1.6 Cr −₹9.9 Cr -348% Total Assets ₹315 Cr ₹42.8 Cr ₹66.3 Cr ₹125 Cr ₹78 Cr +304% EPS ₹-28.05 ₹1.71 ₹-6.8 ₹1 ₹-1.36 -1957% Book Value per Share ₹65.11 ₹13.25 ₹9.9 ₹23.74 ₹15.63 +317%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › » Latest: FY26 · Consolidated CHART » ALPHA AI » COMP » FA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95% .
